ATC 2018

PL04f - Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study

Jun 6, 2018 8:30am ‐ Jun 6, 2018 10:00am


Description


Speaker(s):

You must be logged in and own this session in order to post comments.